PCSK9, FROM GENE AND VARIANTS TO PROTEIN AND PHENOTYPE

被引：0
|
作者：
Abifadel, M. [1 ,2 ]
Bernier, L. [3 ]
Bonneau, J. [1 ]
Marques, A. [1 ]
Marduel, M. [1 ]
Devillers, M. [1 ]
Erlich, D. [1 ]
Rabes, J. -P. [1 ,4 ]
Varret, M. [1 ]
Davignon, J. [3 ]
Boileau, C. [1 ,4 ]
机构：
[1] Hop Necker Enfants Malad, INSERM, U781, F-75743 Paris, France
[2] Univ St Joseph, Fac Pharm, Beirut, Lebanon
[3] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada
[4] CHU Ambroise Pare, Genet Mol, Biochim Lab, Bergen, Norway
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70407-0
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [41] PCSK9, a new gene involved in familial hypercholesteremia
    Lambert, G
    Costet, P
    Krempf, M
    Lalanne, F
    M S-MEDECINE SCIENCES, 2004, 20 (12): : 1068 - 1070
  • [42] PCSK9 pipeline
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (12) : 811 - 811
  • [43] PCSK9 pipeline
    Asher Mullard
    Nature Reviews Drug Discovery, 2016, 15 : 811 - 811
  • [44] PCSK9 GENE PARTICIPATES IN THE DEVELOPMENT OF PRIMARY DYSLIPIDEMIAS
    Matias-Perez, D.
    Perez-Santiago, A. D.
    Medina, Sanchez M. A.
    Alpuche Osorno, J. J.
    Garcia-Montalvo, I. A.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2021, 24 (01) : 5 - 13
  • [45] The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition
    Momtazi-Borojeni, Amir Abbas
    Banach, Maciej
    Ruscica, Massimiliano
    Sahebkar, Amirhossein
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (10) : 1199 - 1208
  • [46] Correlations of PCSK9 and LDLR Gene Polymorphisms and Serum PCSK9 Levels With Atherosclerosis and Lipid Metabolism in Patients on Maintenance Hemodialysis
    Cui, Jun
    Qiu, Yuxiang
    Kang, Ningsu
    Lu, Jianxun
    Zheng, Lu
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (12): : 1430 - 1437
  • [47] PCSK9: From discovery to therapeutic applications
    Farnier, Michel
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2014, 107 (01) : 58 - 66
  • [48] PCSK9: from biology to clinical applications
    Blanchard, Valentin
    Khantalin, Ilya
    Ramin-Mangata, Stephane
    Chemello, Kevin
    Nativel, Brice
    Lambert, Gilles
    PATHOLOGY, 2019, 51 (02) : 177 - 183
  • [49] Variants of PCSK9 are associated with triglyceride levels in the old order Amish
    Able, Samone
    Shuldiner, Alan
    ETHNICITY & DISEASE, 2007, 17 (04) : S39 - S40
  • [50] Variants of PCSK9 Gene Are Associated with Subclinical Atherosclerosis and Cardiometabolic Parameters in Mexicans. The GEA Project
    Zamarron-Licona, Erasmo
    Rodriguez-Perez, Jose Manuel
    Posadas-Sanchez, Rosalinda
    Vargas-Alarcon, Gilberto
    Banos-Gonzalez, Manuel Alfonso
    Borgonio-Cuadra, Veronica Marusa
    Perez-Hernandez, Nonanzit
    DIAGNOSTICS, 2021, 11 (05)
12345